Olof Palmes gata 29 IV, Stockholm, Stockholm County, 11122, Sweden
Drug development company creating treatments for Sickle Cell Disease.
Total Raised
$27 M
Rounds
5
Links
Verticals
Equity
Aug 2025
$3M
Convertible Note
May 2022
$1M
Jul 2021
Series A
Jul 2018
$16M
Feb 2017
$4M
Ellen Wittmack Donnelly
CEO
Mats Wahlgren
Co-Founder, Chief Scientific Officer
Thomas Knittel
Chief Medical Officer
Lena Jendeberg
Vice President, Development
